Prolintane
From Wikipedia, the free encyclopedia
![]() |
|
![]() |
|
Clinical data | |
---|---|
Routes of administration |
oral, intranasal, rectal |
ATC code | N06BX14 (WHO) |
Identifiers | |
|
|
CAS Number | 493-92-5 ![]() |
PubChem (CID) | 14592 |
ChemSpider | 13930 ![]() |
UNII | EM4YZW677H ![]() |
ChEMBL | CHEMBL2111047 ![]() |
ECHA InfoCard | 100.007.077 |
Chemical and physical data | |
Formula | C15H23N |
Molar mass | 217.35 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Prolintane (Catovit, Promotil, Villescon) is a stimulant[1] and norepinephrine-dopamine reuptake inhibitor developed in the 1950s.[2] It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action.[3] Many cases of prolintane abuse have been reported.[4]
See also[edit]
- α-PVP (β-ketone-prolintane, prolintanone)
- Methylenedioxypyrovalerone (MDPV)
- Pyrovalerone (Centroton, Thymergix)
References[edit]
- ^ Hollister, L. E.; Gillespie, H. K. (March–April 1970). "A New Stimulant, Prolintane Hydrochloride, Compared with Dextroamphetamine in Fatigued Volunteers". The Journal of Clinical Pharmacology. 10 (2): 103–109. doi:10.1177/009127007001000205. PMID 4392006.
- ^ GB Patent 807835
- ^ Nicholson, A. N.; Stone, B. M.; Jones, M. M. (November 1980). "Wakefullness and reduced rapid eye movement sleep: studies with prolintane and pemoline.". British Journal of Clinical Pharmacology. 10 (5): 465–472. doi:10.1111/j.1365-2125.1980.tb01790.x. PMC 1430138
. PMID 7437258.
- ^ Kyle, P. B.; Daley, W. P. (September 2007). "Domestic Abuse of the European Rave Drug Prolintane". Journal of Analytical Toxicology. 31 (7): 415–418. doi:10.1093/jat/31.7.415. PMID 17725890.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |